E-DRUG: Independent Drug & Healthcare Newsletter for January 2017
-------------------------------------------------------------------------------------
Newsletter, January 2017
If your friends or colleagues would be interested, forward this email and invite them to sign up for the free Newsletter.
Independent Drug & Healthcare Newsletter
N° 178 January 2017
View the table of contents for the current issue
Subscribe to Prescrire International
In Prescrire's Spotlight this month
-------------------------------------------------------------------------------
RTS,S/AS01E malaria vaccine (Mosquirix°).
Children living in malaria-endemic regions: little efficacy, poorly documented harms
FEATURED REVIEW In late 2016, the harm-benefit balance of the RTS,S/AS01E malaria vaccine is highly uncertain, but its evaluation must continue where the vaccine is much needed.
Read more
-------------------------------------------------------------------------------
In the January issue of Prescrire International:
adverse effects of pseudoephedrine and sofosbuvir
FREE DOWNLOAD In the "Adverse Effects" section of this month's issue, ischaemic colitis with the decongestant pseudoephedrine, and a risk of pulmonary arterial hypertension with the hepatitis C drug sofosbuvir.
Read more
-------------------------------------------------------------------------------
Advanced ovarian cancers:
olaparib negatively impacts the quality of life, without prolonging survival
According to the current, very limited knowledge, the harm-benefit balance of olaparib is unfavourable for patients in remission from ovarian cancer treated with chemotherapy.
Read more
-------------------------------------------------------------------------------
Cholesterol:
slightly higher risk of type 2 diabetes with all statins
Several large-scale studies have revealed an increased risk of type 2 diabetes in patients taking a statin.
Read more
-------------------------------------------------------------------------------
Hypertension:
delicate choice of blood pressure target
Aiming for blood pressure of 120 mm Hg presents advantages and risks, and should be discussed with some patients.
Read more
Prescrire International <international@prescrire.org>